Ambros Pharma S.R.L.
Records under this name other than the patents Ambros Pharma S.R.L. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 2 of 2 · Back to Ambros Pharma S.R.L.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,858,656 | Controlled release formulations containing an active ingredient, preferably melatonin and the method of preparation Term ended Term ended Dec 8, 2021 · USPTO record | Term ended | Term ended Dec 8, 2021 | USPTO record |
| US 6,447,818 | Compositions containing compounds with adrenergic activity and vegetable extracts of Crataegus and gingko biloba for the treatment of overweight and obesity Lapsed on the fee record Ended Sep 10, 2014 · USPTO record | Lapsed on the fee record | Ended Sep 10, 2014 | USPTO record |